Enhanced antitumor efficacy through microwave ablation combined with a dendritic cell-derived exosome vaccine in hepatocellular carcinoma

References

• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Crocetti L, Lencioni R. Thermal ablation of hepatocellular carcinoma. Cancer Imag. 2008;8(1):19–26.
   PubMed Web of Science ®Google Scholar
• Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet. 2012;379(9822):1245–1255.
   PubMed Web of Science ®Google Scholar
• Kang TW, Kim JM, Rhim H, et al. Small hepatocellular carcinoma: radiofrequency ablation versus nonanatomic resection-propensity score analyses of long-term outcomes. Radiology. 2015;275(3):908–919.
   PubMed Web of Science ®Google Scholar
• Li X, Liang P. Immunotherapy for hepatocellular carcinoma following thermal ablation. J Buon. 2014;19(4):867–871.
   PubMed Web of Science ®Google Scholar
• Nakagawa H, Mizukoshi E, Iida N, et al. In vivo immunological antitumor effect of OK-432-stimulated dendritic cell transfer after radiofrequency ablation. Cancer Immunol Immunother. 2014;63(4):347–356.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhai B, Yang W, et al. Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine Mol Ther. 2009;17(12):2049–2057.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Jiang J, Ding J, et al. Microwave ablation combined with dendritic cell vaccine: a potential synergistic therapy for hepatocellular carcinoma. Int J Clin Exp Med. 2019;12(9):11257–11264.
   Web of Science ®Google Scholar
• Palmer DH, Midgley RS, Mirza N, et al. A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma Hepatology. 2009;49(1):124–132.
   PubMed Web of Science ®Google Scholar
• Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nature Rev Cancer. 2012;12(4):265–277.
   PubMed Web of Science ®Google Scholar
• Han Q, Zhao H, Jiang Y, et al. HCC-derived exosomes: critical player and target for cancer immune escape. Cells. 2019;8(6):558.
   Web of Science ®Google Scholar
• Pitt JM, Andre F, Amigorena S, et al. Dendritic cell-derived exosomes for cancer therapy. J Clin Investig. 2016;126(4):1224–1232.
   PubMed Web of Science ®Google Scholar
• Mignot G, Roux S, Thery C, et al. Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med. 2006;10(2):376–388.
   PubMed Web of Science ®Google Scholar
• Lu Z, Zuo B, Jing R, et al. Dendritic cell-derived exosomes elicit tumor regression in autochthonous hepatocellular carcinoma mouse models. J Hepatol. 2017;67(4):739–748.
   PubMed Web of Science ®Google Scholar
• Cho JA, Yeo DJ, Son HY, et al. Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int J Cancer. 2005;114(4):613–622.
   PubMed Web of Science ®Google Scholar
• Slovak R, Ludwig JM, Gettinger SN, et al. Immuno-thermal ablations – boosting the anticancer immune response. J Immunother Cancer. 2017;5(1):78.
   PubMed Web of Science ®Google Scholar
• Mami-Chouaib F, Blanc C, Corgnac S, et al. Resident memory T cells, critical components in tumor immunology. J Immunother Cancer. 2018;6(1):10.
   PubMed Web of Science ®Google Scholar
• Mukai S, Kjaergaard J, Shu SY, et al. Infiltration of tumors by systemically transferred tumor-reactive T lymphocytes is required for antitumor efficacy. Cancer Res. 1999;59(20):5245–5249.
   PubMed Web of Science ®Google Scholar
• Li L, Wang W, Pan H, et al. Microwave ablation combined with OK-432 induces Th1-type response and specific antitumor immunity in a murine model of breast cancer. J Transl Med. 2017;15(1):23.
   PubMed Web of Science ®Google Scholar
• Zhu J, Yu M, Chen L, et al. Enhanced antitumor efficacy through microwave ablation in combination with immune checkpoints blockade in breast cancer: a pre-clinical study in a murine model. Diagn Interventional Imaging. 2018;99(3):135–142.
   PubMed Web of Science ®Google Scholar
• Tanaka A, Sakaguchi S. Regulatory T cells in cancer immunotherapy. Cell Res. 2017;27(1):109–118.
   PubMed Web of Science ®Google Scholar
• Chen ML, Pittet MJ, Gorelik L, et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci USA. 2005;102(2):419–424.
   PubMed Web of Science ®Google Scholar
• Lee WC, Wu TJ, Chou HS, et al. The impact of CD4+ CD25+ T cells in the tumor microenvironment of hepatocellular carcinoma. Surgery. 2012;151(2):213–222.
   PubMed Web of Science ®Google Scholar
• Kobayashi N, Hiraoka N, Yamagami W, et al. FOXP3(+) regulatory T cells affect the development and progression of hepatocarcinogenesis. Clin Cancer Res. 2007;13(3):902–911.
   PubMed Web of Science ®Google Scholar
• Kurzrock R. Cytokine deregulation in cancer. Biomed Pharmacother. 2001;55(9–10):543–547.
   PubMed Web of Science ®Google Scholar
• Beatty GL, Paterson Y. Regulation of tumor growth by IFN-gamma in cancer immunotherapy. IR. 2001;24(2):201–210.
   Web of Science ®Google Scholar
• Sato T, Terai M, Tamura Y, et al. Interleukin 10 in the tumor microenvironment: a target for anticancer immunotherapy. Immunol Res. 2011;51(2-3):170–182.
   PubMed Web of Science ®Google Scholar
• Botella-Estrada R, Escudero M, O'Connor JE, et al. Cytokine production by peripheral lymphocytes in melanoma. Eur Cytokine Network. 2005;16(1):47–55.
   PubMed Web of Science ®Google Scholar
• Rao Q, Zuo B, Lu Z, et al. Tumor-derived exosomes elicit tumor suppression in murine hepatocellular carcinoma models and humans in vitro. Hepatology. 2016;64(2):456–472.
   PubMed Web of Science ®Google Scholar
• Thery C, Duban L, Segura E, et al. Indirect activation of naïve CD4+ T cells by dendritic cell-derived exosomes. Nat Immunol. 2002;3(12):1156–1162.
   PubMed Web of Science ®Google Scholar
• Bronte V, Pittet MJ. The spleen in local and systemic regulation of immunity. Immunity. 2013;39(5):806–818.
   PubMed Web of Science ®Google Scholar
• Lemdani K, Mignet N, Boudy V, et al. Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma. Oncoimmunology. 2019;8(3):1550342.
   PubMed Web of Science ®Google Scholar